Veterans who paired a GLP-1 with six to eight habits had a 43% lower cardiovascular risk

About 1 in 8 US adults say they are taking a GLP-1 medicine, and a February study of more than 98,000 US military veterans found that those who used one and held six to eight healthy habits had a 43% lower risk of serious cardiovascular events, including stroke and heart attack, than people who used no such drug and held three or fewer.

Doctors who treat obesity keep landing on the same sentence: the prescription is not the treatment. These medicines act on gut and brain signals that slow digestion and dial down appetite, which is what makes eating habits, movement and sleep easier to change rather than beside the point, and a review of nearly three dozen studies found the effect is larger and lasts longer when both arrive together.

None of that turns willpower into the ingredient that was missing. Obesity is a chronic, progressive condition, the pressure to read it as a personal failing is older than any of these medicines, and a survey of who is taking them says nothing about who can afford to keep taking them or who has an hour a day to move. The harder question is whether a health system willing to pay for the prescription also pays for the food, the coaching and the time.

Read the full story at AP News ↗

Retatrutide is investigational and is not FDA-approved. Other medicines referenced here are covered as third-party news for educational awareness only. Catalyst does not present this information as medical advice, treatment guidance, or a claim of safety, efficacy, or approval.